Zojirushi Corporation (7965.T)
JPY 1830.0
(0.77%)
JPY 1830.0
(0.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 83.49 Billion | 82.53 Billion | 77.67 Billion | 74.94 Billion | 79.11 Billion | 84.63 Billion |
| Cost of Revenue | 57.36 Billion | 57.54 Billion | 51.02 Billion | 49.62 Billion | 52.98 Billion | 56.36 Billion |
| Gross Profit | 26.13 Billion | 24.98 Billion | 26.65 Billion | 25.32 Billion | 26.12 Billion | 28.26 Billion |
| Operating Expenses | 21.13 Billion | 20.32 Billion | 20.25 Billion | 19.88 Billion | 20.68 Billion | 22.01 Billion |
| Selling, General and Administrative Expenses | 20.21 Billion | 19.41 Billion | 18.58 Billion | 18.08 Billion | 19.02 Billion | 20.38 Billion |
| Research and Development Expenses | 959 Million | 882 Million | 784 Million | 818 Million | 845 Million | 780 Million |
| Other Expenses | 139 Million | 20.32 Billion | 20.25 Billion | 19.88 Billion | 20.68 Billion | 22.01 Billion |
| Cost and Expenses | 78.39 Billion | 77.86 Billion | 71.27 Billion | 69.5 Billion | 73.66 Billion | 78.38 Billion |
| Operating Income | 5.09 Billion | 4.66 Billion | 6.39 Billion | 5.44 Billion | 5.44 Billion | 6.25 Billion |
| Interest Expense | 83 Million | 67 Million | 27 Million | 34 Million | 7 Million | 9 Million |
| Income Tax Expense | 1.87 Billion | 2.06 Billion | 2.29 Billion | 1.63 Billion | 1.71 Billion | 1.95 Billion |
| Earnings before Tax | 6.44 Billion | 5.71 Billion | 6.82 Billion | 5.62 Billion | 5.88 Billion | 6.52 Billion |
| Net Income | 4.44 Billion | 3.65 Billion | 4.5 Billion | 3.94 Billion | 4.08 Billion | 4.43 Billion |
| Earnings Per Share Basic | 65.63 | 54.08 | 66.68 | 58.32 | 60.39 | 65.61 |
| Earnings Per Share Diluted | 65.63 | 54.08 | 66.68 | 58.32 | 60.39 | 65.61 |
| Weighted Average Shares Outstanding | 67.66 Million | 67.64 Million | 67.62 Million | 67.6 Million | 67.59 Million | 67.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 67.66 Million | 67.64 Million | 67.62 Million | 67.6 Million | 67.59 Million | 67.57 Million |
| Gross Margin | 0.31 | 0.30 | 0.34 | 0.34 | 0.33 | 0.33 |
| EBIT Margin | 0.11 | 0.10 | 0.11 | 0.11 | 0.10 | 0.10 |
| Profit Margin | 0.05 | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 |
| EBITDA | 8.78 Billion | 7.74 Billion | 8.93 Billion | 8 Billion | 7.94 Billion | 8.63 Billion |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.08 | 0.07 | 0.07 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 18.16 Billion | 19.42 Billion | 28.14 Billion | 83.49 Billion | 21.55 Billion | 16.49 Billion |
| Cost of Revenue | 12.61 Billion | 13.29 Billion | 18.75 Billion | 57.36 Billion | 15.08 Billion | 11.91 Billion |
| Gross Profit | 5.54 Billion | 6.13 Billion | 9.38 Billion | 26.13 Billion | 6.47 Billion | 4.57 Billion |
| Operating Expenses | 5.44 Billion | 5.29 Billion | 5.86 Billion | 21.03 Billion | 5.66 Billion | 4.84 Billion |
| Selling, General and Administrative Expenses | 5.44 Billion | 4.97 Billion | 5.86 Billion | - | 5.41 Billion | 4.65 Billion |
| Research and Development Expenses | - | 320 Million | 172 Million | - | 261 Million | 194 Million |
| Other Expenses | - | 57 Million | 52 Million | 139 Million | 8 Million | 56 Million |
| Cost and Expenses | 18.05 Billion | 18.58 Billion | 24.61 Billion | 78.39 Billion | 20.75 Billion | 16.76 Billion |
| Operating Income | 107 Million | 846 Million | 3.52 Billion | 5.09 Billion | 806 Million | -273 Million |
| Interest Expense | 16 Million | 17 Million | 19 Million | 83 Million | 21 Million | 20 Million |
| Income Tax Expense | 136 Million | 987 Million | 1.18 Billion | 1.87 Billion | 339 Million | 96 Million |
| Earnings before Tax | 142 Million | 3.15 Billion | 3.94 Billion | 6.44 Billion | 1.05 Billion | 65 Million |
| Net Income | 43 Million | 2.13 Billion | 2.69 Billion | 4.44 Billion | 730 Million | -21 Million |
| Earnings Per Share Basic | 0.67 | 31.54 | 39.83 | - | 10.79 | -0.31 |
| Earnings Per Share Diluted | 0.67 | 31.54 | 39.83 | - | 10.79 | -0.31 |
| Weighted Average Shares Outstanding | 65.59 Million | 67.69 Million | 67.67 Million | 67.66 Million | 67.67 Million | 67.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.59 Million | 67.69 Million | 67.67 Million | 67.66 Million | 67.67 Million | 67.67 Million |
| Gross Margin | 0.31 | 0.32 | 0.33 | 0.31 | 0.30 | 0.28 |
| EBIT Margin | 0.04 | 0.07 | 0.14 | - | 0.07 | 0.01 |
| Profit Margin | 0.00 | 0.11 | 0.10 | 0.05 | 0.03 | -0.00 |
| EBITDA | 758 Million | 1.41 Billion | 3.96 Billion | - | 1.44 Billion | 105 Million |
| Earnings Before Tax Margin | 0.01 | 0.04 | 0.13 | 0.06 | 0.04 | -0.02 |
0HOH
BIOEX
GXI
050890
5821
GEN